Comprehensive characterization and validation of the Prp-hPFN1G118V mouse model: Guidelines for preclinical therapeutic testing for ALS
Neurobiology of Disease · 2025
DOI: 10.1016/j.nbd.2025.106975 ↗Kurz gefasst
Leitlinie in der Zeitschrift Neurobiology of Disease, 2025. Verfasst von Kaly A Mueller und 8 weiteren Autor:innen. Beteiligte Einrichtung: ALS Therapy Development Institute, 480 Arsenal Street, Watertown, MA, USA. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Disease Models, Animal, Profilins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ALS Therapy Development Institute, 480 Arsenal Street, Watertown, MA, USA.
- Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, 70 Ship St, Providence, RI, USA.
- ALS Therapy Development Institute, 480 Arsenal Street, Watertown, MA, USA. Electronic address: thatzipetros@als.net.
Zitieren
APA
Mueller, K. A., Suneby, E. G., Ferola, M. H., Moreno, A. J., Kidd, J. D., Thompson, K., Vieira, F. G., Valdez, G., & Hatzipetros, T. (2025). Comprehensive characterization and validation of the Prp-hPFN1G118V mouse model: Guidelines for preclinical therapeutic testing for ALS. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2025.106975
Vancouver
Mueller KA, Suneby EG, Ferola MH, Moreno AJ, Kidd JD, Thompson K, et al. Comprehensive characterization and validation of the Prp-hPFN1G118V mouse model: Guidelines for preclinical therapeutic testing for ALS. Neurobiology of Disease. 2025. doi:10.1016/j.nbd.2025.106975
BibTeX
@article{Mueller2025,
author = {Mueller, Kaly A and Suneby, Emma G and Ferola, Matthew H and Moreno, Andy J and Kidd, Joshua D and Thompson, Kenneth and Vieira, Fernando G and Valdez, Gregorio and Hatzipetros, Theo},
title = {Comprehensive characterization and validation of the Prp-hPFN1G118V mouse model: Guidelines for preclinical therapeutic testing for ALS},
journal = {Neurobiology of Disease},
year = {2025},
doi = {10.1016/j.nbd.2025.106975}
}
EUVIMED